Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs

Journal of Veterinary Pharmacology and Therapeutics
Y F ZhouY H Liu

Abstract

The pharmacokinetics and bioavailability of cefquinome in Beagle dogs were determined by intravenous (IV), intramuscular (IM) or subcutaneous (SC) injection at a single dose of 2 mg/kg body weight (BW). The minimum inhibitory concentrations (MIC) of cefquinome against 217 Escherichia coli isolated from dogs were also investigated. After IV injection, the plasma concentration-time curve of cefquinome was analyzed using a two-compartmental model, and the mean values of t1/2α (h), t1/2β (h), Vss (L/kg), ClB (L/kg/h) and AUC (μg·h/mL) were 0.12, 0.98, 0.30, 0.24 and 8.51, respectively. After IM and SC administration, the PK data were best described by a one-compartmental model with first-order absorption. The mean values of t1/2Kel , t1/2Ka , tmax (h), Cmax (μg/mL) and AUC (μg·h/mL) were corresponding 0.85, 0.14, 0.43, 4.83 and 8.24 for IM administration, 0.99, 0.29, 0.72, 3.88 and 9.13 for SC injection. The duration of time that drug levels exceed the MIC (%T > MIC) were calculated using the determined MIC90 (0.125 μg/mL) and the PK data obtained in this study. The results indicated that the dosage regimen of cefquinome at 2 mg/kg BW with 12-h intervals could achieve %T > MIC above 50% that generally produced a satisfactory bacter...Continue Reading

References

Apr 1, 1978·Journal of Pharmacokinetics and Biopharmaceutics·K YamaokaT Uno
Aug 1, 1995·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·A BöttnerR Humke
Dec 17, 2004·Journal of Veterinary Pharmacology and Therapeutics·P L Toutain, A Bousquet-Mélou
Dec 17, 2004·Journal of Veterinary Pharmacology and Therapeutics·P L Toutain, P Lees
Nov 13, 2008·Journal of Veterinary Pharmacology and Therapeutics·X B LiJ Z Shen
Jan 5, 2011·American Journal of Veterinary Research·Liguo YuanYahong Liu
May 28, 2011·Journal of Veterinary Pharmacology and Therapeutics·Y H HwangH I Yun
Aug 11, 2012·The Journal of Veterinary Medical Science·In Bae SongHyo In Yun
Nov 30, 2012·Journal of Veterinary Pharmacology and Therapeutics·D H ZhaoY H Liu
Mar 5, 2013·Tropical Animal Health and Production·Venkatathalam DinakaranPritam Kaur Sidhu
Mar 13, 2014·Antimicrobial Agents and Chemotherapy·Jing WangZhenling Zeng

❮ Previous
Next ❯

Citations

May 10, 2020·Acta Veterinaria Hungarica·Abdullah AltaybanMohammed Al-Nazawi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.